At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Sorted Ascending Title Type Shares Traded Price Range
Mar 15, 2013 barer sol j Director Buy 25,000 3.40
Nov 4, 2009 barer sol j Director Buy 20,000 4.13
Jun 5, 2007 barkas alexander e Director Option Execute 15,119 6.38
Jun 5, 2007 barkas alexander e Director Acquisition (Non Open Market) 2,232,060 n/a
Jun 5, 2007 barkas alexander e Director Sell 6,427 15.00
Mar 7, 2012 barrett m james Director Buy 925,154 5.70
Mar 7, 2012 barris peter j Beneficial Owner (10% or more) Buy 1,140,000 5.70
Jul 25, 2007 barris peter j Beneficial Owner (10% or more) Acquisition (Non Open Market) 29,447 11.49
Jun 5, 2007 barris peter j Beneficial Owner (10% or more) Option Execute 15,077 6.38
Jun 5, 2007 barris peter j Beneficial Owner (10% or more) Acquisition (Non Open Market) 4,472,224 n/a
Jun 5, 2007 barris peter j Beneficial Owner (10% or more) Sell 6,408 15.00
Feb 11, 2009 bloch stephen m Director Sell 1,908 9.42
Dec 8, 2008 bloch stephen m Director Automatic Sell 3,000 8.54
Dec 3, 2008 bloch stephen m Director Automatic Sell 25 8.50
Dec 2, 2008 bloch stephen m Director Automatic Sell 1,544 8.50
Dec 1, 2008 bloch stephen m Director Automatic Sell 4 8.90
Nov 28, 2008 bloch stephen m Director Automatic Sell 3,000 8.50
Nov 26, 2008 bloch stephen m Director Automatic Sell 3,000 8.52
Nov 24, 2008 bloch stephen m Director Automatic Sell 3,000 8.52
Nov 21, 2008 bloch stephen m Director Automatic Sell 2,436 8.50
Showing 1-20 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy